KU ASH 2019 Review: Current Updates in Hematologic Diseases
H

ASH 2019 Update: Understanding the Leukemia Mutational Profile in a Timely Fashion Helps "Unfit" & R/R AML Patients

By KU ASH 2019 Review: Current Updates in Hematologic Diseases FEATURING Heather Male
By KU ASH 2019 Review: Current Updates in Hematologic Diseases FEATURING Heather Male
108 views
February 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
22:37
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…

Feat. T. Badar
50:34
Scripps MD Anderson Cancer Center

The Cure of Leukemias in the Next Decade: An Optimist’s View

Feat. H. Kantarjian
19:10
5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center

Feat. H. Kantarjian
09:51
i3 Health

MRD Testing in Leukemias: When Negativity Is a Positive Thing

Feat. N. S. Raje
14:19
Talha Badar

Challenges in the Management of TP53-Mutated AML: Potential Strategi…

22:30
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Emerging Treatment Options for AML in 2024

Feat. A. Perl
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Immunotherapies in Acute Leukemias: 2024 Update

Feat. C. Lai
12:28
Roswell Park Comprehensive Cancer Center

Current Landscape of R/R AML Treatment

Feat. E. Wang
27:28
UChicago Medicine

AML: Current Treatment Landscape and Key Recent Updates

Feat. A. Patel
02:52
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From a Phase 1 Clinical Study of …

Feat. M. Amaya
32:04
Moffitt Cancer Center

Experts Discuss the Latest Data in Myeloid Diseases

Feat. A. Kuykendall, R. Komrokji, O. Chan, D. Sallman
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
15:45
SOHO 2022 Tenth Annual Meeting

SOHO 2022: How Do We Overcome Resistance to Venetoclax in AML

Feat. M. Konopleva
16:11
MyCancerHaven

Experts Discuss the Use of Targeted Therapies in AML

Feat. R. Vij, E. Wang
04:11
Total Health

ASCO 2022 Updates in Leukemia and MDS

Feat. D. Sallman
19:51
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A 50-Year Personal Perspective on the Treatment of AML

Feat. C. Schiffer
11:41
Penn Medicine Abramson Cancer Center

Penn Medicine Updates From Recent Meetings in Hematologic Malignanci…

Feat. C. Lai
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
10:41
ASH 2022 Conference Coverage

ASH 2022 Triplet Combination of Azacitidine, Venetoclax, and Gilteri…

Feat. N. Short
10:31
SOHO Turkey 2023

SOHO Turkey 2023: How I Treat AML

Feat. F. Ravandi